Diabetes Drug Actos To Be Advertised In A Big Way In The USA
Nov 18th 2007Drug InformationDiabetes
The makers of Actos (pioglitazone), Takeda Pharmaceutical Company Ltd., announced they are to launch a large advertising campaign in the USA for their diabetes drug; following a safety warning issued a day before for Avandia (rosiglitazone), a rival medication. Local and weekly newspapers throughout the country will feature full-page adverts. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
